Peripheral Intravenous Line Survival and Phlebitis Prevention in Patients Receiving Intravenous Antibiotics: Heparin/Hydrocortisone versus In-Line Filters

OBJECTIVE: To compare the use of in-line filtration with the addition of heparin/hydrocortisone (hep/hc) to the infusate for both phlebitis prevention and intravenous(iv) line survival in peripheral iv catheters. This study was specific for a patient group receiving prolonged courses of iv antibiotics. Analysis of the two endpoints for conventional short iv catheters (short lines) versus long (30 cm) iv catheters (long lines) was also performed. METHODS: Patients with cystic fibrosis receiving intermittent iv antibiotics were randomly allocated to receive their drugs either through an in-line filter using a drug-free infusate or with no filter and an infusate containing heparin 500 units and hydrocortisone 10 mg/L. Infusion sites were assessed daily. RESULTS: Both the hep/hc and filter groups were similar in terms of phlebitis incidence and iv line survival when analyzed separately for both short and long lines. Long lines displayed markedly prolonged survival times and reduced phlebitis compared with short lines. CONCLUSIONS: The effectiveness of iv filters in excluding the large particle load introduced by iv antibiotics and hence in reducing the subsequent phlebitis makes them a useful alternative to the use of hep/hc. The use of filters in this patient group may offer advantages in terms of ease of use and a possible decrease in hep/hc-related problems. Long lines offer practical advantages over short lines for patients requiring longer term iv access.

[1]  J. Hecker Potential for extending survival of peripheral intravenous infusions. , 1992, BMJ.

[2]  E. Noris,et al.  Pediatric i.v. catheters: efficacy of saline flush. , 1992, Pediatric nursing.

[3]  M. Ringer,et al.  Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. , 1991, Annals of internal medicine.

[4]  J. Hecker Survival of intravenous chemotherapy infusion sites. , 1990, British Journal of Cancer.

[5]  J. Sussmane Prolonged intravenous infusions. , 1989, American journal of diseases of children.

[6]  J. Williams,et al.  Silastic catheters for antibiotics in cystic fibrosis. , 1988, Archives of disease in childhood.

[7]  N. Kirkham,et al.  Plastic material from a syringe causing fatal bowel necrosis in a neonate , 1988, British medical journal.

[8]  C. S. Nelson Advances in Pediatrics. Volume 33 , 1987 .

[9]  D. Silver,et al.  The heparin-induced thrombocytopenia syndrome: an update. , 1987, Surgery.

[10]  C. Backhouse,et al.  Particulate contaminants of intravenous medications and infusions , 1987, The Journal of pharmacy and pharmacology.

[11]  J. Doty,et al.  Heparin-associated thrombocytopenia in the neurosurgical patient. , 1986, Neurosurgery.

[12]  P. Heeger,et al.  Heparin flushes and thrombocytopenia. , 1986, Annals of internal medicine.

[13]  R. C. Oppenheim,et al.  Particulate contamination in plastic ampoules , 1986, The Journal of pharmacy and pharmacology.

[14]  T. G. Baumgartner,et al.  Bacterial endotoxin retention by inline intravenous filters. , 1986, American journal of hospital pharmacy.

[15]  B. McNeil,et al.  Microparticulate-induced phlebitis. Its prevention by in-line filtration. , 1985, The New England journal of medicine.

[16]  C. McLaren,et al.  Intravenous Therapy Team and Peripheral Venous Catheter—Associated Complications: A Prospective Controlled Study , 1984 .

[17]  M. Bassan,et al.  Prevention of lidocaine-infusion phlebitis by heparin and hydrocortisone. , 1983, Chest.

[18]  C. Mccollum,et al.  Final inline filtration for intravenous infusions: A prospective hospital study , 1983, The British journal of surgery.

[19]  W. Rusho,et al.  Effect of filtration on complications of postoperative intravenous therapy. , 1979, American journal of hospital pharmacy.

[20]  R. Schreiner,et al.  Systemic vascular cotton fiber emboli in the neonate. , 1979, The Journal of pediatrics.

[21]  B. Bivins,et al.  Final inline filtration: a means of decreasing the incidence of infusion phlebitis. , 1979, Surgery.

[22]  B. Bivins,et al.  Inflammatory Potential of Foreign Particulates in Parenteral Drugs , 1977, Anesthesia and analgesia.

[23]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[24]  B. Bivins,et al.  Filtration and infusion phlebitis: a double-blind prospective clinical study. , 1975, American journal of hospital pharmacy.

[25]  R. Bergstrom,et al.  Stability of parenteral solutions of tobramycin sulfate. , 1975, American journal of hospital pharmacy.

[26]  H. Yamamori,et al.  Evaluation of the endotoxin retention capabilities of inline intravenous filters. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[27]  K. A. Dietrich,et al.  Use of a single silastic IV catheter for cystic fibrosis pulmonary exacerbations , 1988, Pediatric pulmonology.

[28]  H. Mckean,et al.  Double-blind study to investigate methods to prevent cephalothin-induced phlebitis. , 1977, American journal of hospital pharmacy.